Interspecies transmission and chikungunya virus emergence

Konstantin A. Tsetsarkin, Rubing Chen, Scott Weaver

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Chikungunya virus (CHIKV) causes severe, debilitating, often chronic arthralgia with high attack rates, resulting in severe morbidity and economic costs to affected communities. Since its first well-documented emergence in Asia in the 1950s, CHIKV has infected millions and, since 2007, has spread widely, probably via viremic travelers, to initiate urban transmission in Europe, the South Pacific, and the Americas. Some spread has been facilitated by adaptive envelope glycoprotein substitutions that enhance transmission by the new vector, Aedes albopictus. Although epistatic constraints may prevent the impact of these mutations in Asian strains now circulating in the Americas, as well as in African CHIKV strains imported into Brazil last year, these constraints could eventually be overcome over time to increase the transmission by A. albopictus in rural and temperate regions. Another major determinant of CHIKV endemic stability in the Americas will be its ability to spill back into an enzootic cycle involving sylvatic vectors and nonhuman primates, an opportunity exploited by yellow fever virus but apparently not by dengue viruses.

Original languageEnglish (US)
Pages (from-to)143-150
Number of pages8
JournalCurrent Opinion in Virology
Volume16
DOIs
StatePublished - Feb 1 2016

Fingerprint

Chikungunya virus
Yellow fever virus
Dengue Virus
Aptitude
South America
Aedes
Arthralgia
Primates
Brazil
Glycoproteins
Economics
Morbidity
Costs and Cost Analysis
Mutation

ASJC Scopus subject areas

  • Virology

Cite this

Interspecies transmission and chikungunya virus emergence. / Tsetsarkin, Konstantin A.; Chen, Rubing; Weaver, Scott.

In: Current Opinion in Virology, Vol. 16, 01.02.2016, p. 143-150.

Research output: Contribution to journalArticle

Tsetsarkin, Konstantin A. ; Chen, Rubing ; Weaver, Scott. / Interspecies transmission and chikungunya virus emergence. In: Current Opinion in Virology. 2016 ; Vol. 16. pp. 143-150.
@article{6e127c0550b44bd68315ac0a5f282060,
title = "Interspecies transmission and chikungunya virus emergence",
abstract = "Chikungunya virus (CHIKV) causes severe, debilitating, often chronic arthralgia with high attack rates, resulting in severe morbidity and economic costs to affected communities. Since its first well-documented emergence in Asia in the 1950s, CHIKV has infected millions and, since 2007, has spread widely, probably via viremic travelers, to initiate urban transmission in Europe, the South Pacific, and the Americas. Some spread has been facilitated by adaptive envelope glycoprotein substitutions that enhance transmission by the new vector, Aedes albopictus. Although epistatic constraints may prevent the impact of these mutations in Asian strains now circulating in the Americas, as well as in African CHIKV strains imported into Brazil last year, these constraints could eventually be overcome over time to increase the transmission by A. albopictus in rural and temperate regions. Another major determinant of CHIKV endemic stability in the Americas will be its ability to spill back into an enzootic cycle involving sylvatic vectors and nonhuman primates, an opportunity exploited by yellow fever virus but apparently not by dengue viruses.",
author = "Tsetsarkin, {Konstantin A.} and Rubing Chen and Scott Weaver",
year = "2016",
month = "2",
day = "1",
doi = "10.1016/j.coviro.2016.02.007",
language = "English (US)",
volume = "16",
pages = "143--150",
journal = "Current Opinion in Virology",
issn = "1879-6257",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Interspecies transmission and chikungunya virus emergence

AU - Tsetsarkin, Konstantin A.

AU - Chen, Rubing

AU - Weaver, Scott

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Chikungunya virus (CHIKV) causes severe, debilitating, often chronic arthralgia with high attack rates, resulting in severe morbidity and economic costs to affected communities. Since its first well-documented emergence in Asia in the 1950s, CHIKV has infected millions and, since 2007, has spread widely, probably via viremic travelers, to initiate urban transmission in Europe, the South Pacific, and the Americas. Some spread has been facilitated by adaptive envelope glycoprotein substitutions that enhance transmission by the new vector, Aedes albopictus. Although epistatic constraints may prevent the impact of these mutations in Asian strains now circulating in the Americas, as well as in African CHIKV strains imported into Brazil last year, these constraints could eventually be overcome over time to increase the transmission by A. albopictus in rural and temperate regions. Another major determinant of CHIKV endemic stability in the Americas will be its ability to spill back into an enzootic cycle involving sylvatic vectors and nonhuman primates, an opportunity exploited by yellow fever virus but apparently not by dengue viruses.

AB - Chikungunya virus (CHIKV) causes severe, debilitating, often chronic arthralgia with high attack rates, resulting in severe morbidity and economic costs to affected communities. Since its first well-documented emergence in Asia in the 1950s, CHIKV has infected millions and, since 2007, has spread widely, probably via viremic travelers, to initiate urban transmission in Europe, the South Pacific, and the Americas. Some spread has been facilitated by adaptive envelope glycoprotein substitutions that enhance transmission by the new vector, Aedes albopictus. Although epistatic constraints may prevent the impact of these mutations in Asian strains now circulating in the Americas, as well as in African CHIKV strains imported into Brazil last year, these constraints could eventually be overcome over time to increase the transmission by A. albopictus in rural and temperate regions. Another major determinant of CHIKV endemic stability in the Americas will be its ability to spill back into an enzootic cycle involving sylvatic vectors and nonhuman primates, an opportunity exploited by yellow fever virus but apparently not by dengue viruses.

UR - http://www.scopus.com/inward/record.url?scp=84960941126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960941126&partnerID=8YFLogxK

U2 - 10.1016/j.coviro.2016.02.007

DO - 10.1016/j.coviro.2016.02.007

M3 - Article

C2 - 26986235

AN - SCOPUS:84960941126

VL - 16

SP - 143

EP - 150

JO - Current Opinion in Virology

JF - Current Opinion in Virology

SN - 1879-6257

ER -